Article Sidebar

PDF
Date Published: 15/11/2021
Abstract Views: 28
Views PDF: 42
DOI: https://doi.org/10.60117/vjmap.v40i7.198
Issue
Vol. 40 No. 7 (2021)
Section
Research Articles
How to Cite
Trịnh, T. C., & Nguyễn, T. T. H. (2021). Outcomes of concurrent chemoradiotherapy in patients of stage iii adenocarcinoma of the lung. Viet Nam Journal of Traditional Medicine and Pharmacy, 40(7), 24-27. https://doi.org/10.60117/vjmap.v40i7.198

Outcomes of concurrent chemoradiotherapy in patients of stage iii adenocarcinoma of the lung

Thế Cường Trịnh, Thị Thái Hòa Nguyễn

Main Article Content

Abstract

Objects: To evaluate of concurrent pemetrexed-cisplatin and thoracic radiation therapy in patients with stage III adenocarcinoma of the lung.


Subjects and methods: The cross-sectional study was conducted on 31 patients diagnosed stage III lung adenocarcinoma, treated by pemetrexed-cisplatin regimen combined thoracic radiation therapy at Vietnam national cancer hospital from 3/2018 to 8/2020.


Results: Of our 31 patients, overall response rate and disease control accounted for 54,8% and 90,3% respectively. Toxicities are mainly grade 1, 2.


Conclusion: Pemetrexed-cisplatin combined with thoracic radiation therapy has a high response as well as high control disease rate, good patient tolerance and less common side effects at grade 3, 4.

Article Details

Keywords

Stage III lung adenocarcinoma, concurrent chemoradiotherapy, pemetrexed-cisplatin.

References

1. R Molina, P Yang, SD Cassivi, etal: Non- small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship Mayo Clin Proc 83:584–594,2008. .
2. D Morgensztern, SH Ng, F Gao, etal: Trends in stage distribution for patients with non-small cell lung cancer: A Nationa. D Morgensztern, SH Ng, F Gao, etal: Trends in stage distribution for patients with non-small cell lung cancer: A National Cancer Database survey J Thorac Oncol 5:29–33,2010.
3. Vansteenkiste J., De Ruysscher D., Eberhardt
W.E.E. et al (2013). Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 24(suppl_6), vi89–vi98.
4. Senan S., Brade A., Wang L et al (2016). PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non–Small-Cell Lung Cancer. JCO, 34(9), 953–962.
5. Nguyễn Việt Long (2010): Đánh giá hiệu quả hóa xạ trị đồng thời điều trị UTPKTB tại Bệnh viện K, Đại học Y Hà Nội, Luận án thạc sỹ y học, Trường Đại học Y Hà Nội.